Highland Capital Management, LLC Amgen Inc Transaction History

Highland Capital Management, LLC

  • $1.68 Billion
  • Q2 2024

A detailed history of Highland Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Highland Capital Management, LLC holds 6,402 shares of AMGN stock, worth $2.05 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
6,402
Previous 7,617 15.95%
Holding current value
$2.05 Million
Previous $2.17 Million 7.62%
% of portfolio
0.12%
Previous 0.12%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024
SELL
$262.75 - $319.31 $319,241 - $387,961
-1,215 Reduced 15.95%
6,402 $2 Million
Q1 2024

May 07, 2024
BUY
$268.87 - $324.56 $2,419 - $2,921
9 Added 0.12%
7,617 $2.17 Million
Q4 2023

Jan 17, 2024
SELL
$255.7 - $288.46 $6,136 - $6,923
-24 Reduced 0.31%
7,608 $2.19 Million
Q3 2023

Nov 14, 2023
SELL
$218.65 - $271.46 $30,611 - $38,004
-140 Reduced 1.8%
7,632 $2.05 Million
Q2 2023

Aug 09, 2023
SELL
$214.27 - $253.37 $5,785 - $6,840
-27 Reduced 0.35%
7,772 $1.73 Million
Q1 2023

May 11, 2023
SELL
$225.79 - $275.2 $267,109 - $325,561
-1,183 Reduced 13.17%
7,799 $1.89 Million
Q4 2022

Feb 07, 2023
BUY
$229.03 - $291.01 $220,326 - $279,951
962 Added 12.0%
8,982 $2.36 Million
Q3 2022

Nov 09, 2022
SELL
$224.46 - $253.15 $23,343 - $26,327
-104 Reduced 1.28%
8,020 $1.81 Million
Q2 2022

Jul 14, 2022
BUY
$230.71 - $256.74 $1,153 - $1,283
5 Added 0.06%
8,124 $1.98 Million
Q1 2022

Apr 19, 2022
BUY
$219.27 - $242.57 $7,016 - $7,762
32 Added 0.4%
8,119 $1.96 Million
Q4 2021

Jan 28, 2022
SELL
$198.88 - $227.6 $19,888 - $22,760
-100 Reduced 1.22%
8,087 $1.82 Million
Q3 2021

Oct 25, 2021
SELL
$212.27 - $248.7 $151,136 - $177,074
-712 Reduced 8.0%
8,187 $1.74 Million
Q2 2021

Jul 30, 2021
SELL
$233.58 - $259.14 $82,687 - $91,735
-354 Reduced 3.83%
8,899 $2.17 Million
Q1 2021

Apr 27, 2021
SELL
$221.91 - $258.6 $158,665 - $184,899
-715 Reduced 7.17%
9,253 $2.3 Million
Q4 2020

Jan 21, 2021
SELL
$216.38 - $257.67 $4.21 Million - $5.02 Million
-19,472 Reduced 66.14%
9,968 $2.29 Million
Q3 2020

Oct 16, 2020
SELL
$234.65 - $260.95 $196,402 - $218,415
-837 Reduced 2.76%
29,440 $7.48 Million
Q2 2020

Jul 22, 2020
BUY
$197.81 - $242.74 $623,299 - $764,873
3,151 Added 11.62%
30,277 $7.14 Million
Q1 2020

May 05, 2020
BUY
$182.24 - $241.7 $1.16 Million - $1.53 Million
6,343 Added 30.52%
27,126 $5.5 Million
Q4 2019

Feb 05, 2020
SELL
$189.21 - $243.2 $2.34 Million - $3.01 Million
-12,383 Reduced 37.34%
20,783 $5.01 Million
Q3 2019

Nov 20, 2019
SELL
$174.11 - $208.62 $2.07 Million - $2.47 Million
-11,861 Reduced 26.34%
33,166 $6.42 Million
Q2 2019

Jul 29, 2019
BUY
$166.7 - $195.41 $2.12 Million - $2.49 Million
12,731 Added 39.42%
45,027 $8.3 Million
Q1 2019

Apr 18, 2019
SELL
$180.87 - $203.88 $112,501 - $126,813
-622 Reduced 1.89%
32,296 $6.14 Million
Q4 2018

Jan 16, 2019
SELL
$178.4 - $208.25 $539,660 - $629,956
-3,025 Reduced 8.42%
32,918 $6.41 Million
Q3 2018

Oct 17, 2018
BUY
$185.29 - $208.89 $1.57 Million - $1.77 Million
8,486 Added 30.91%
35,943 $7.45 Million
Q2 2018

Jul 18, 2018
BUY
$166.05 - $186.51 $43,505 - $48,865
262 Added 0.96%
27,457 $5.07 Million
Q1 2018

Apr 16, 2018
BUY
$169.43 - $198.0 $22,195 - $25,938
131 Added 0.48%
27,195 $4.64 Million
Q4 2017

Jan 26, 2018
SELL
$168.79 - $188.59 $83,382 - $93,163
-494 Reduced 1.79%
27,064 $4.71 Million
Q3 2017

Oct 10, 2017
BUY
$167.29 - $191.0 $4.61 Million - $5.26 Million
27,558
27,558 $5.14 Million

Others Institutions Holding AMGN

# of Institutions
3,057
Shares Held
409M
Call Options Held
7.19M
Put Options Held
6.3M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Highland Capital Management, LLC Portfolio

Follow Highland Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email